Skip to content
PPD - Part of Thermo Fisher Scientific
Main Menu
Insights Hub
Careers
Contact Us
Investors
Newsroom
Japan
Search
Search
Search for:
Who We Are
Show submenu
Our Mission
Show submenu
Accolades
Our History
Our 4i Values
Our Work
Show submenu
Our Solutions
How We Help
Therapeutic Areas
Corporate Responsibility
Show submenu
Environmental Stewardship
Health and Wellness
Philanthropy
PPD Heroes
Locations
Company Resources
Show submenu
Vendor Resources
Legal Notices
Privacy Policy
Events
Newsroom
Ethics
Investors
How We Help
Show submenu
Clinical Trial Certainty/Reliability
Data Capabilities
Decentralized Clinical Trials
Show submenu
Choosing DCTs
DCT Capabilities and Solutions
DCT Therapeutic Expertise
Why PPD DCT
Resources
Ensuring Patient Diversity in Clinical Trials
Expertise in Asia-Pacific
Show submenu
PPD in China
PPD-SNBL in Japan
Functional Service Partnership Solutions
Industry Trends
PPD Biotech Solutions
Site and Patient Recruitment Solutions
Our Customers
Show submenu
Consumer Health
PPD Biotech Solutions
Government and Public Health
Medical Device Development
Our Solutions
Show submenu
Clinical Development
Show submenu
Early Development
Phase II-IV Clinical Trial Management
Show submenu
Biostatistics
Clinical Data Management
Clinical Trial Monitoring
Clinical Trial Project Management
Global Clinical Supplies
Medical Writing
Pharmacokinetic and Pharmacodynamic
Pharmacovigilance
Peri- and Post-approval
Show submenu
Data and Real-World Evidence
Evidence Synthesis, Modeling and Communication
Interventional Studies
Non-Interventional Studies
Pharmacovigilance
PPD Biotech Solutions
PPD Functional Service Partnership Solutions
Show submenu
Biostatistics and Programming
Clinical Data Management
Clinical Operations
Medical Writing
Pharmacovigilance
Project Delivery
Regulatory Affairs
Site Contracts and Payments
Site Support
Study Startup
Quality Assurance
Insights Hub: PPD FSP Solutions
PPD Translate
Medical Communications
Product Development and Consulting
Show submenu
Integrated Clinical Development Consulting
Quality and Enterprise Learning
Regulatory Affairs Solutions
Site and Patient Centric Solutions
Show submenu
Accelerated Enrollment Solutions (AES)
Enrollment and Site Activation
Integrating the Patient Voice
Leveraging Technology
Reducing Patient Burden
Technology
Show submenu
Data Capabilities
Decentralized Clinical Trials
Information Security
Preclarus
Support Systems and Services
PPD® Laboratory Services
Show submenu
Bioanalytical Lab
Show submenu
Bioanalytical Lab Capabilities
Bioanalytical Lab Experience and Expertise
PPD® Laboratories Tech Talks
Bioanalytical Lab Resources
Biomarker Lab
Show submenu
Biomarker Lab Capabilities
Biomarker Lab Resources
Central Lab
Show submenu
Central Lab Capabilities
Certifications
Preclarus Lab Solutions
Central Lab Resources
GMP Lab
Show submenu
GMP Lab Capabilities
GMP Lab Experience and Expertise
Athlone Lab
GMP Lab Resources
Vaccine Sciences Lab
Show submenu
Vaccine Sciences Lab Capabilities
Vaccine Sciences Lab Resources
Lab Services in China
PPD Laboratory Services FSP
Therapeutic Areas
Show submenu
Biosimilars Development
Cardiovascular
Cell & Gene Therapy
Critical Care
Dermatology
Hepatology
Gastroenterology
Immunology and Rheumatology
Infectious Diseases
Metabolic and Endocrine
Show submenu
Diabetes
Rare Metabolic Disease
Nephrology and Renal Diseases
Neuroscience Research
Show submenu
Neurodegenerative Disease Research Expertise
Psychiatry
Neuroinflammatory Diseases
Oncology and Hematology
Ophthalmology
Pediatrics
Rare Diseases
Show submenu
Neuromuscular Disorder Studies
Rare Metabolic Disease
Rare Neurological Disorders
Respiratory
Urology
Vaccine Development
Women’s Health
Participate in a Trial
Search for:
Roche case study 1
an early indication of potential beneficial effects of an intervention
